18F-FDG PET as a Surrogate Biomarker in Non–Small Cell Lung Cancer Treated with Erlotinib: Newly Identified Lesions Are More Informative Than Standardized Uptake Value
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.